Health and Wellness
GLP-1 Drugs and Cancer Risk: What the Research Shows
Emerging research suggests GLP-1 receptor agonists like semaglutide and tirzepatide may do more than help with weight loss, potentially reducing the risk of certain cancers progressing. Here is what the current evidence shows, what remains unknown, and what questions to bring to your doctor.